Literature DB >> 8530316

[Jugular vein thrombosis as incidental ultrasound finding in tumor patients].

P R Issing1, T Ohmayer, M Schönermark, W Dillo, T Lenarz.   

Abstract

At present thrombosis of the internal jugular vein is an uncommon event that is now more frequently associated with diagnostic or therapeutic catheterization. If an apparent spontaneous thrombosis occurs, malignancy should be considered in the differential diagnosis. Two cases of clinically asymptomatic thrombosis of the internal jugular vein are presented. A 69-year-old female patient with metastasizing renal cell carcinoma had bilateral thrombosis and a 73-year-old male with a small laryngeal carcinoma had a unilateral thrombosis. Increased blood coagulability as part of a paraneoplastic syndrome was considered to be the possible etiology. The role of sonography in the diagnosis is emphasized.

Entities:  

Mesh:

Year:  1995        PMID: 8530316

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  5 in total

Review 1.  [Jugular vein thrombosis caused by hypercoagulability following in-vitro fertilization-activated protein C resistance and immobilization].

Authors:  K Stölzel; S Jovanovic; A E Albers
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

2.  Subclavian vein thrombosis: an unusual presentation of renal cell carcinoma.

Authors:  Ammar Hameed; Ajay Pahuja; Ali Thwaini; Thiagarajan Nambirajan
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

Review 3.  [Diagnosis and treatment of jugular vein thrombosis].

Authors:  P R Issing; C Issing
Journal:  HNO       Date:  2019-06       Impact factor: 1.284

4.  [Internal jugular vein thrombosis as a paraneoplastic syndrome].

Authors:  J Stern-Sträter; K Hörmann; W Neff; B A Stuck
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

5.  [Superior vena cava syndrome with bilateral jugular and subclavian vein thrombosis. Paraneoplastic manifestion of renal cell carcinoma].

Authors:  M May; M Seehafer; C Helke; T Uberrück; S Gunia; B Hoschke
Journal:  Urologe A       Date:  2003-10       Impact factor: 0.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.